Table 2.

Correlation of serum exosomal MAGEA3 and MAGEA4 expression and clinicopathological parameters.

Clinicopathological factor	n	MAGEA3 serum exosome		n	MAGEA4 serum exosome
		Mean ± SEM	P		Mean ± SEM	P
Age(year)			0.1414			0.8863
< 60	35	1.153 ± 0.1895		30	2.138 ± 0.3521
≥ 60	27	1.960 ± 0.5666		23	2.221 ± 0.4727
Gender			0.1476			0.3117
Male	23	2.017 ± 0.5765		20	1.802 ± 0.4019
Female	39	1.202 ± 0.2600		33	2.399 ± 0.3833
Diameter			0.7723			0.6400
< 2	39	1.567 ± 0.3479		34	2.200 ± 0.3720
≥ 2	15	1.768 ± 0.6551		13	2.529 ± 0.5716
Stage			0.1492			0.8776
< II	42	1.233 ± 0.2610		39	2.200 ± 0.3499
≥ II	20	2.073 ± 0.6307		14	2.100 ± 0.4659
T			0.6924			0.2933
Tis + 1	45	1.472 ± 0.2919		40	2.374 ± 0.3567
≥ 2	15	1.730 ± 0.7122		12	1.652 ± 0.3335
N			0.018			0.8856
0	48	1.210 ± 0.2401		42	2.228 ± 0.3506
≥ 1	12	2.842 ± 0.9551		10	2.121 ± 0.2623
M			0.9807			0.6519
0	49	1.508 ± 0.3147		43	2.112 ± 0.3194
≥ 1	13	1.491 ± 0.5380		10	2.442 ± 0.6310
CEA			0.1858			0.6929
< 5 ng/ml	44	1.135 ± 0.2388		23	2.214 ± 0.4702
≥ 5 ng/ml	13	1.868 ± 0.6309		25	1.972 ± 0.3949
NSE			0.8648			0.9833
< 16.3 ng/ml	36	1.388 ± 0.3599		34	2.116 ± 0.4057
≥ 16.3 ng/ml	7	1.245 ± 0.3410		5	2.093 ± 0.4284

Significant values are in bold.